CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric study.

Riedinger, J M

CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric study. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology Aug 2006 - 1234-8 p. digital

Publication Type: Journal Article; Multicenter Study

0923-7534

10.1093/annonc/mdl120 doi


Adult
Aged
Aged, 80 and over
Biomarkers, Tumor--analysis
CA-125 Antigen--analysis
Carcinoma--drug therapy
Female
Half-Life
Humans
Middle Aged
Ovarian Neoplasms--drug therapy
Prognosis
Survival Analysis
Treatment Outcome